Come visit us at BioTechX in Basel next week to discuss all topics around AI in Drug Discovery and Development and Clinical Trial Analytics Services. We look forward to meeting colleagues from across the industry. My colleague Greg Lever will also be presenting a great talk "Guiding Assets from Discovery through Development" (which is sitting under in the AI in Drug Development and Discovery track), on: ~ Demonstrating how Large Language Models enable you to scan the emerging scientific landscape and explore new targets, new markets, new indications, identify obstacles and assess development timelines ~ Exploring AI/ML approaches that can be used to identify new targets for assets, identify associations between targets and indications, and repurpose existing drugs for new indications ~ Describing downstream applications of AI/ML to improve patient identification and recruitment, including within underrepresented populations Join us at #biotechxEU — booth 702. https://bit.ly/480H6QG #pharmaceutical #ai #drugdiscovery #development #BiotexhxEU
See how to connect the right data, technology and expertise for insights that transform clinical R&D! Join us at #biotechxEU — booth 702. https://bit.ly/480H6QG #pharmaceutical #ai #drugdiscovery #development #BiotexhxEU